These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1940 related items for PubMed ID: 19765187

  • 1. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY, Park HJ, Ahn YH, Lee PH.
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice.
    Sakai R, Irie Y, Murata T, Ishige A, Anjiki N, Watanabe K.
    Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N, Ferger B.
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
    Arias RL, Sung ML, Vasylyev D, Zhang MY, Albinson K, Kubek K, Kagan N, Beyer C, Lin Q, Dwyer JM, Zaleska MM, Bowlby MR, Dunlop J, Monaghan M.
    Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547
    [Abstract] [Full Text] [Related]

  • 17. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 20. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
    Jiang H, Li LJ, Wang J, Xie JX.
    Exp Neurol; 2008 Aug 15; 212(2):532-7. PubMed ID: 18577498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.